In a Parkinson’s disease (PD) model, Li et al., (2017a, b) observed progressive declines in serum antioxidant enzyme activities (SOD, GPX, GST) and increases in oxidative damage markers (e.g., MDA and GSH), accompanied by compensatory gene upregulation and dopaminergic neuronal loss. This evidence concerns the gene SOD1 and Parkinson disease.